The stock of SPECTRAL MED INC ORDINARY SHARES (OTCMKTS:EDTXF) registered a decrease of 0.56% in short interest. EDTXF’s total short interest was 178,400 shares in December as published by FINRA. Its down 0.56% from 179,400 shares, reported previously. With 12,800 shares average volume, it will take short sellers 14 days to cover their EDTXF’s short positions.
It closed at $0.4827 lastly. It is down 0.00% since December 4, 2018 and is . It has by 0.00% the S&P500.
Spectral Medical Inc. focuses on the development and commercialization of theranostic treatment for septic shock in North America. The company has market cap of $108.60 million. The companyÂ’s products include Endotoxin Activity Assay, a rapid diagnostic test for the detection of components of gram negative bacterial cell wall in Europe and Japan; and Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream worldwide. It currently has negative earnings. It also develops, produces, and markets recombinant cardiac proteins, antibodies, and calibrators for use in research and development, as well as in products manufactured by other diagnostic companies.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.